Literature DB >> 15849673

[The cost of cerebrovascular accident].

J M Beguiristain1, J Mar, A Arrazola.   

Abstract

INTRODUCTION AND AIM: One out of three persons will die of cerebrovascular accident (CVA), another one will be disabled, and the third one will recover. This research has been taken to estimate the costs of CVA in the Basque Country.
MATERIALS AND METHODS: The cost of illness is studied from a societal perspective. It is based on the prevalence of the disease. Population costs has been estimated from the use of resources of a randomized sample of patients admitted to hospital with stroke during the year 2000, and followed for 12 months. Transitions costs (those that happen just once) and state costs (those remaining in patients lifetime) have been studied separately.
RESULTS: The prevalence of CVA was 1.780 x 10(5). Average transition cost per patient was 4,762 euros and average state cost for patient/year was 10,506 euros. The estimated cost for the Basque Country is 120,249,986 euros in the year 2000. Transition costs were 16,460,729 euros and state costs 103,789,257 euros in the same year. State costs were due to disability.
CONCLUSIONS: The analysis of the costs of CVA from a societal perspective gets us to the heart of illness causing disability, the social costs of CVA are 74.3% of the total cost.

Entities:  

Mesh:

Year:  2005        PMID: 15849673

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  8 in total

1.  Revealing the association between cerebrovascular accidents and ambient temperature: a meta-analysis.

Authors:  Andrés Zorrilla-Vaca; Ryan Jacob Healy; Melissa M Silva-Medina
Journal:  Int J Biometeorol       Date:  2016-10-28       Impact factor: 3.787

2.  Economic impact of patients admitted to stroke units in Spain.

Authors:  Jose Alvarez-Sabín; Manuel Quintana; Jaime Masjuan; Juan Oliva-Moreno; Javier Mar; Nuria Gonzalez-Rojas; Virginia Becerra; Covadonga Torres; María Yebenes
Journal:  Eur J Health Econ       Date:  2016-04-15

3.  Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain.

Authors:  Julio Lopez-Bastida; Juan Oliva Moreno; Melany Worbes Cerezo; Lilisbeth Perestelo Perez; Pedro Serrano-Aguilar; Fernando Montón-Álvarez
Journal:  BMC Health Serv Res       Date:  2012-09-12       Impact factor: 2.655

Review 4.  Cost of disorders of the brain in Spain.

Authors:  Oleguer Parés-Badell; Gabriela Barbaglia; Petra Jerinic; Anders Gustavsson; Luis Salvador-Carulla; Jordi Alonso
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

5.  Development and Validation of a Discrete Event Simulation Model to Evaluate the Cardiovascular Impact of Population Policies for Obesity.

Authors:  Arantzazu Arrospide; Oliver Ibarrondo; Iván Castilla; Igor Larrañaga; Javier Mar
Journal:  Med Decis Making       Date:  2021-10-11       Impact factor: 2.583

6.  Cost-Utility Analysis of Magnetic Resonance Imaging Management of Patients with Acute Ischemic Stroke in a Spanish Hospital.

Authors:  Elizabeth Parody; Salvador Pedraza; María M García-Gil; Carlos Crespo; Joaquín Serena; Antoni Dávalos
Journal:  Neurol Ther       Date:  2015-05-19

7.  Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention.

Authors:  Itziar Oyagüez; Carmen Suárez; José Luis López-Sendón; José Ramón González-Juanatey; Fernando de Andrés-Nogales; Jorge Suárez; Carlos Polanco; Javier Soto
Journal:  Pharmacoecon Open       Date:  2020-09

8.  [Cost-effectiveness analysis of apixaban versus acetylsalicylic acid in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain].

Authors:  Ginés Escolar-Albaladejo; Gonzalo Barón-Esquivias; José Luis Zamorano; Lourdes Betegón-Nicolás; Cristina Canal-Fontcuberta; Marina de Salas-Cansado; Darío Rubio-Rodríguez; Carlos Rubio-Terrés
Journal:  Aten Primaria       Date:  2016-01-30       Impact factor: 1.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.